Cargando…
Efficacy and Safety of NOACs Compared With VKAs for Patients With Atrial Fibrillation After Transcatheter Aortic Valve Implantation: A System Review and Meta-Analysis
Novel oral anticoagulants (NOACs) are preferentially recommended in patients with nonvalvular atrial fibrillation (AF) for stroke prevention over vitamin K antagonists (VKAs). However, the evidence regarding the efficacy and safety of NOACs versus VKAs after transcatheter aortic valve implantation (...
Autores principales: | Ge, Junye, Han, Wenqiang, Ma, Chuanzhen, Maduray, Kellina, Chen, Tongshuai, Zhong, Jingquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9768833/ https://www.ncbi.nlm.nih.gov/pubmed/36524251 http://dx.doi.org/10.1177/10760296221145168 |
Ejemplares similares
-
Association of acetaldehyde dehydrogenase 2 rs671 polymorphism with the occurrence and progression of atrial fibrillation
por: Ge, Junye, et al.
Publicado: (2022) -
A prediction model of atrial fibrillation recurrence after first catheter ablation by a nomogram: HASBLP score
por: Han, Wenqiang, et al.
Publicado: (2022) -
The risk factors of thrombus formation and the effect of catheter ablation on repetitive thrombus formation in patients with atrial fibrillation: a single center retrospective study in China
por: Liu, Huiyu, et al.
Publicado: (2023) -
Post-TAVR patients with atrial fibrillation: are NOACs better than VKAs?—A meta-analysis
por: Wang, Lu, et al.
Publicado: (2023) -
Access Site Bleeding Complications with NOACs versus VKAs in Patients with Atrial Fibrillation Undergoing Cardiac Implantable Device Intervention
por: Spinoni, Enrico Guido, et al.
Publicado: (2022)